Pulished Date October, 2018
ID: 2701
Share on
Share on

North America Non-Invasive Prenatal Testing Market By Instruments (Ultrasound, NGS, PCR, Microarray), Method (FCMB, Cf-DNA), By Application (Trisomy, Microdeletion, Genetics, Rh Factor), By End User (Hospital, Diagnostic Labs) And By Region -Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Pulished: October, 2018
ID: 2701
Pages: 150

The North America Non-Invasive Prenatal Testing Market was worth USD 0.63 Billion in 2018 and is projected to be growing at a CAGR of 16.2%, to touch USD 1.33 Billion by 2023. Non-Invasive Prenatal Testing consists of the non-invasive procedure of screening a pregnant mother’s blood for pinpointing the abnormalities (if any) in a baby(foetus). Non-invasive Prenatal Testing is also used to determine the gender of a foetus.

NIPT helps in the identification of the most common genetic abnormalities or disorders which include Down Syndrome, Edwards Syndrome and the Patau Syndrome among others. These disorders are identified by analysing the cell free DNA known as cf-DNA.

The growth of the North American Non-Invasive Prenatal Testing Market is mainly driven by factors such as the feasibility and growing preference for non-invasive techniques over invasive ones, increasing risk of chromosomal abnormalities in babies with growing maternal age and favourable reimbursement for NIPT. The lower clinical validity of tests and the possibility of false positives are among the restraints faced by the market.

The North America Non-Invasive Prenatal Testing Market is segmented based on Instruments, Method of Screening, Application, End User and geography. Based on Instruments, the market is divided into Ultrasound, NGS, PCR and Microarray. Based on Method, market is segmented into FCMB and cf-DNA. Further, by Application, the market is branched into Trisomy, Microdeletion, Genetics, and Rh factor. Based on the End User, it is categorized into Hospital and Diagnostic Labs.

The North American market has been geographically segmented into segmented into US and Canada. North America took the major chunk of the global Non-Invasive Prenatal Testing market share in 2016, with the U.S. accounting for a major share. Swift introduction of new technologies driven by the increasing incidence of genetic abnormalities due to the growing maternal age are driving the North American Non-Invasive Prenatal Testing Market.

The North America Non-Invasive Prenatal Testing market is very much fragmented in nature with the presence of global and local players. The important players in the North America Non-Invasive Prenatal Testing market are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Instruments                               

                                5.1.1 Introduction           

                                5.1.2 PCR            

                                5.1.3 Ultrasound              

                                5.1.4 NGS           

                                5.1.5 Microarray              

                                5.1.6  Y-o-Y Growth Analysis, By Instruments     

                                5.1.7  Market Attractiveness Analysis, By Instruments   

                                5.1.8  Market Share Analysis, By Instruments     

                5.2 Method                       

                                5.2.1 Introduction           

                                5.2.2 FCMB        

                                5.2.3 Cell-Free DNA (cf-DNA)     

                                5.2.4 Y-o-Y Growth Analysis, By Method               

                                5.2.5 Market Attractiveness Analysis, By Method             

                                5.2.6 Market Share Analysis, By Method              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Trisomy    

                                5.3.3 Microdeletion        

                                5.3.4 Genetics  

                                5.3.5 Rh factor  

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7  Market Attractiveness Analysis, By Application      

                                5.3.8  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospital    

                                5.4.3 Diagnostic Labs      

                                5.4.4 Y-o-Y Growth Analysis, By End User             

                                5.4.5  Market Attractiveness Analysis, By End User          

                                5.4.6  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Instruments

                                                6.1.3.3 By Method

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Instruments

                                                6.1.4.3 By Method

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Instruments

                                                6.1.5.3 By Method

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 GE Healthcare                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Koninklijke Philips N.V                           

                8.3 Thermo Fisher Scientific                        

                8.4 Hoffman-La Roche                  

                8.5 Pacific Biosciences of California                          

                8.6 PerkinElmer                               

                8.7 QIAGEN N.V                               

                8.8 Agilent Technologies                              

                8.9 Beijing Genomics Institute                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  2. North America Ultrasound Market By Region, From 2018-2023 ( USD Billion )
  3. North America NGS Market By Region, From 2018-2023 ( USD Billion )
  4. North America PCR Market By Region, From 2018-2023 ( USD Billion )
  5. North America Microarray Market By Region, From 2018-2023 ( USD Billion )
  6. North America Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  7. North America FCMB Market By Region, From 2018-2023 ( USD Billion )
  8. North America cf-DNA Market By Region, From 2018-2023 ( USD Billion )
  9. North America Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  10. North America Trisomy Market By Region, From 2018-2023 ( USD Billion )
  11. North America Microdeletion Market By Region, From 2018-2023 ( USD Billion )
  12. North America Genetics Market By Region, From 2018-2023 ( USD Billion )
  13. North America Rh Factor Market By Region, From 2018-2023 ( USD Billion )
  14. North America Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  15. North America Hospital Market By Region, From 2018-2023 ( USD Billion )
  16. North America Diagnostic Labs Market By Region, From 2018-2023 ( USD Billion )
  17. United States Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  18. United States Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  19. United States Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  20. United States Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
  21. Canada Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
  22. Canada Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
  23. Canada Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
  24. Canada Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients

Research Areas